Utility of the Comprehensive Trail Making Test in the Assessment of Mild Cognitive Impairment in Older Patients

Author:

Bednorz Adam12ORCID,Religa Dorota34ORCID

Affiliation:

1. John Paul II Geriatric Hospital, 40-353 Katowice, Poland

2. Institute of Psychology, Humanitas Academy, 41-200 Sosnowiec, Poland

3. Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 77 Stockholm, Sweden

4. Theme Inflammation and Aging, Karolinska University Hospital, 141 86 Huddinge, Sweden

Abstract

Introduction. The purpose of this study is to determine the usefulness of the CTMT (Comprehensive Trail Making Test) in diagnosing mild cognitive impairment in older patients. The test is used to assess executive functions, of which impairment is already observed in the early stages of the neurodegenerative process. Materials and Methods. The study includes 98 patients of a geriatric ward assigned to 2 groups of 49 patients each: patients diagnosed with a mild cognitive impairment and patients without a cognitive impairment, constituting the control group (group K). A set of screening tests was used in the initial study: the MMSE (Mini-Mental State Examination), MoCA (Montreal Cognitive Assessment), and CDT (Clock Drawing Test), GDS (Geriatric Depression Scale). The second study included the performance of the CTMT; the performance indicator was the time of performance. Results. Statistically significant differences are obtained between patients with mild cognitive impairments and those in cognitive normality in the performance of the CTMT test (p < 0.01). Patients with MCIs took longer to complete all trails of the test. To identify cognitive impairment, cutoff points were proposed for the CTMT total score and the other test trails. The CTMT overall score and CTMT 5 scored the highest AUCs (CTMT overall score = 0.77, CTMT Trail 5 = 0.80). Conclusions. The Comprehensive Trail Making Test may be useful in diagnosing mild cognitive impairment as a complementary screening tool.

Publisher

MDPI AG

Subject

Geriatrics and Gerontology,Gerontology,Aging,Health (social science)

Reference52 articles.

1. Advancing research diagnostic criteria for Alzheimer’s disease: The IWG-2 criteria;Dubois;Lancet Neurol.,2014

2. Gramkow, M.H., Gjerum, L., Koikkalainen, J., Lötjönen, J., Law, I., Hasselbalch, S.G., Waldemar, G., and Frederiksen, K.S. (2020). Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort. PeerJ, 8.

3. A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in Belgium;Somers;J. Alzheimer’s Dis.,2016

4. Platform Trials to Expedite Drug Development in Alzheimer’s Disease: A Report from the EU/US CTAD Task Force;Aisen;J. Prev. Alzheimer’s Dis.,2021

5. Comparative Analysis of Different Definitions of Amyloid-β Positivity to Detect Early Downstream Pathophysiological Alterations in Preclinical Alzheimer;Shekari;J. Prev. Alzheimer’s Dis.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3